Background The angiotensin I-converting enzyme (ACE) is a key component of the renin-angiotensin system thought to be important in the pathogenesis of hypertension and cardiovascular disease. Deletion polymorphism in the ACE gene may be a risk factor for myocardial infarction in the Caucasian population. However, this finding has not yet been investigated in the Japanese population.
Methods and Results A 287-bp insertion/deletion polymorphism in intron 16 of the ACE gene was examined by polymerase chain reaction in a cross-sectional study of 100 healthy subjects and 178 patients with coronary artery disease (CAD) (70 angina pectoris, 108 myocardial infarction), whose serum ACE levels were concomitantly measured. Polymorphism of the ACE gene was characterized by three genotypes: two deletion alleles (genotype DD), two polymorphism was significantly greater in patients with myocardial infarction than in control subjects in a Caucasian population. This finding suggested that genetic variation in or near the ACE locus may be involved in the pathogenesis of cardiovascular disease.
The purpose of this study was to investigate the correlation of the 287-bp ACE/ID polymorphism with serum ACE activity and CAD in the Japanese.
Methods Subjects
This study consisted of 100 healthy subjects and 178 patients with CAD (70 angina pectoris, 108 myocardial infarction) in Japan. Mean DNA was isolated from peripheral blood leukocytes by use of a DNA extraction kit (Stratagene).
Southern Blot Analysis of Human Genomic DNA High-molecular-weight DNA samples (5 gg) were incubated with restriction enzyme Sac I (Boehringer Mannheim). Digested DNAs were electrophoresed through a 1% agarose gel, transferred to nylon membrane (Pall), and hybridized with a 32P-labeled 247-bp Sac I / Kpn I genomic fragment that contained 247 bp of intron 16 of ACE gene. The filter was washed with 2x SSC, 0.1% SDS, and 0.2x SSC, 0. 1% SDS at 52°C and exposed to x-ray film (Kodak).
Polymerase Chain Reaction for Detection of ACE Insertion/Deletion Polymorphism
Template DNA (100 ng) was used in a polymerase chain reaction (PCR) under stringent conditions to avoid the possibility of false positives.10'11 The sense oligonucleotide primer was 5' CTG CAG ACC ACT CCC ATC CTT TCT 3', and the antisense primer was 5' GAT GTG GCC ATC ACA TTC GTC AGA T 3'. Reactions were performed in a final volume of 100 gL containing 25 pmol of primer, 1.5 mmol/L MgCI2, 50 mmol/L KCI, 10 mmol/L Tris-HCI (pH 8.3), 0.1 mg/mL gelatin, 0.5 mmol/L of each dNTP, and 2.5 U of Taq polymerase (Perkin-Elmer/Cetus). Amplification was carried out in a DNA Thermal Cycler (PC-700, Sci-Media Ltd) for 30 cycles with steps of denaturation at 93°C for 1.5 minutes, annealing at 58°C for 2 minutes, and extension at 72°C for 2 minutes. PCR products were electrophoresed on 1.2% agarose gels, and DNA was visualized by ethidium bromide staining.
Statistical Analysis
Data of total cholesterol, HDL cholesterol, body mass index (BMI), and serum ACE activity were presented as mean± SD.
The differences between groups were analyzed by unpaired Student's t test. Data were compiled according to genotype, and allele frequencies were calculated. Statistical analysis required calculation of the observed number of alleles from genotype data in each group. The difference between groups was then tested by multiple group contingency table analysis.
A value of P<.05 was considered significant.
Results
Clinical parameters -age, BMI, total cholesterol, and HDL cholesterol -are listed in Table 1 Table 2 . The results showed a relation between the ACE gene polymorphism and the serum ACE level. ACE genotypes and derived allele frequencies are shown in Table 3 . The genotype DD characterized by two short alleles was more strongly associated with CAD compared with the two other genotypes (ID and II). The frequency of deletion alleles (D) was higher (0.58) in the CAD group than in normal subjects (0.42). Statistical analysis (Table 3) showed that values for the CAD group differed significantly from those for the healthy control (X2=13, P<.01).
The relation between coronary lesions and the ACE/ID polymorphism is shown in 
Discussion
The ACE deletion polymorphism detected by PCR analysis appears to be associated with serum ACE level and increased risk for CAD in the Japanese.
It is a common observation that there is a patient population without classic risk factors who develop myocardial infarction. It is very important to identify this population for the purpose of primary or secondary prevention of myocardial infarction. Most genetic studies on CAD have focused on genes involved in lipid metabolism.1213 Cambien and colleagues8 showed that the ACE gene may affect myocardial infarction independently of lipid metabolism. Recently, Pfeffer and colleagues5 found that administration of an ACE inhibitor not only decreased the risk for developing heart failure but also reduced the risk of recurrent myocardial infarction.
ACE is a key component of the renin-angiotensin system that has long been considered to play a role in the pathogenesis of hypertension and cardiovascular disease.3'4 The ACE gene, which spans Rigat et a17 and Tiret et a117 originally detected the insertion/deletion polymorphism in the ACE gene locus using an ACE cDNA probe that spanned the complete endothelial ACE mRNA sequence. The polymorphism was detected with the restriction enzyme Hind III. The insertion allele was designated I and the deletion allele, D. They reported that marked differences in serum ACE levels of healthy subjects were found among the three genotypes. Subjects with the deletion polymorphism had higher serum ACE levels than those with the insertion polymorphism. Since the major effect of this polymorphism was reflected in different serum ACE levels, they concluded that the ACE gene played a significant role in the pathogenesis of essential hypertension.
In the ECTIM study, the data of Cambien et a18 suggested that a deletion polymorphism in the gene encoding ACE was a risk factor for myocardial infarction in the Caucasian population, particularly in those otherwise thought to be at low risk for cardiovascular disease. In the present study, the frequency of genotype DD was more strongly associated with CAD in Japanese patients. The frequencies were 25%, 34%, and 41% for genotypes II, ID, and DD, respectively, for Japanese patients with CAD, whereas they were 17%, 51%, and 32%, respectively, for Caucasian patients with CAD. The frequency of deletion allele (D) was higher (0.58) in the CAD group than in normal subjects (0.42). Furthermore, multivessel disease was more significantly associated with genotype DD than with genotype II. These findings suggest that the ACE/ID polymorphism plays a significant role in development of CAD in the Japanese as well as in Caucasian populations.
Since the insertion/deletion polymorphism in the ACE gene lies within an intron and there is no evidence 
